Diabetes Drug Found Not to Cause Pancreatic Cancer
The use of incretin-based drugs is not associated with an increased risk of pancreatic cancer in patients with type 2 diabetes, according to a study published in the latest issue of the British Medical Journal (BMJ). The research was conducted by the Canadian Network for Observational Drug Effect Studies (CNODES), which used the health records of almost 1 million patients with types 2 diabetes.
Incretin-based drugs are widely used in the treatment of type 2 diabetes, but there have been concerns that their use may stimulate pancreatic duct cells in a way that might lead to pancreatic cancer. However, in this, the largest study conducted to date, the researchers found no association between these drugs and pancreatic cancer… Read More>>